Project Grant PAWOS000023

This Project Grant award from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) will fund a two-phase, $873,810 study on barriers to pregnancy care in the Midwest following recent policy changes restricting abortion access. In the first 6-month R61 phase, the research team will recruit 500 pregnant individuals seeking abortion information online to identify and...

This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $702,000 to support a 3-year project aimed at optimizing the implementation of long-acting injectable pre-exposure prophylaxis (LAI-PrEP) for HIV prevention. The key objectives are to: 1) Identify barriers and facilitators to LAI-PrEP implementation, 2) Determine optimal implementation strategies in partnership with...

This $1,163,796 Project Grant, awarded by the National Institute of Child Health and Human Development under the Child Health and Human Development Extramural Research program (CFDA 93.865), will support a 4-year study entitled "Adaptations and Impacts Understanding Teen Pregnancy Prevention Programs" (AIM-UP). The study aims to advance understanding of how evidence-based teen pregnancy prevention programs can be effectively adapted and replicated, with a focus on four key areas:...

This federal Project Grant award of $709,872 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) aims to develop and pilot test a couple-based intervention to address perinatal depression and improve adherence to prevention of mother-to-child transmission (PMTCT) of HIV in Malawi. The key objectives are to: 1) develop a couple-based intervention using problem-solving therapy and content on couple...

This $715,041 Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) will support research to understand real-world choices, preferences, and outcomes related to the roll-out of oral and long-acting injectable PrEP (pre-exposure prophylaxis) among women in Malawi. The study, titled "Better Info on Women's PrEP Choices and Outcomes in Malawi", has three specific aims: 1) Evaluate longitudinal patterns of oral...

The Regents of the University of Minnesota received a $1,078,000 Project Grant award from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865). The grant, awarded on August 22, 2024, will fund a research project titled "Informing Optimal Investments along the Preconception to Postpartum EMTCT Continuum." The project aims to evaluate the population-level effectiveness and...

The Missouri Department of Health & Senior Services (MDHSS) was awarded a $357,558 Formula Grant under the Affordable Care Act (ACA) Personal Responsibility Education Program (PREP) by the U.S. Department of Health and Human Services Administration for Children and Families. The grant, effective from October 1, 2024 to September 30, 2027, supports comprehensive sexual health education and youth development services for adolescents aged 10-19 and pregnant or parenting youth under 21. The PREP...

The Great Plains Tribal Leaders Health Board (GPTLHB) was awarded a $350,000 Cooperative Agreement from the U.S. Department of Health and Human Services under the HIV Prevention Activities Non-Governmental Organization Based program (CFDA 93.939). The five-year award, effective September 1, 2024, aims to develop and implement effective community-based HIV, hepatitis C, and syphilis prevention programs for American Indian and Alaska Native populations in the Great Plains region, which includes...

This Project Grant award from the National Institutes of Health (NIH) under the Trans-NIH Research Support program (CFDA 93.310) aims to integrate a pharmacy technician-based model for delivering long-acting injectable cabotegravir-rilpivirine (LA-CAB/RPV) into community-based Federally Qualified Health Centers (FQHCs) that serve underserved people with HIV. The $1.2M award to the University of Chicago will fund a 5-year study to adapt and test this model in 5 FQHC clinics in Chicago,...

This Project Grant award from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (CFDA 93.865 - Child Health and Human Development Extramural Research) provides $518,754 to Magee-Womens Research Institute and Foundation to develop a bioadhesive vaginal film for extended release of multipurpose technology (MPT) antibodies. The goal is to create a film that can provide contraception and antiviral protection (against HIV and HSV) for up to 7 days from a single...